<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Investing in the Biotech Sector: Five Biotech Stocks for Your Watch List</title>
	<atom:link href="http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html/feed" rel="self" type="application/rss+xml" />
	<link>http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html</link>
	<description>Investment Advice and Investment Research with a Contrarian Point of View</description>
	<lastBuildDate>Thu, 24 May 2012 17:20:29 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
	<item>
		<title>By: noel harris</title>
		<link>http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html#comment-29560</link>
		<dc:creator>noel harris</dc:creator>
		<pubDate>Mon, 16 Nov 2009 00:19:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/investing-in-the-biotech-sector.html#comment-29560</guid>
		<description>hello, 
thanks for the info and recommendations.
 
a quick question: have you heard of a company named &#039;accuray&#039; and the cancer fighting system they have developed called &#039;cyberknife&#039;?

would you put your money into this company?

many thanks, 
noel h.</description>
		<content:encoded><![CDATA[<p>hello,<br />
thanks for the info and recommendations.</p>
<p>a quick question: have you heard of a company named &#8216;accuray&#8217; and the cancer fighting system they have developed called &#8216;cyberknife&#8217;?</p>
<p>would you put your money into this company?</p>
<p>many thanks,<br />
noel h.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chet Billingsley, CEO - MNTR</title>
		<link>http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html#comment-29502</link>
		<dc:creator>Chet Billingsley, CEO - MNTR</dc:creator>
		<pubDate>Sun, 15 Nov 2009 03:45:35 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/investing-in-the-biotech-sector.html#comment-29502</guid>
		<description>Mike  --  Love your reports.  Our firm, Mentor Capital (MNTR) has taken its first and a very large position in Quantum Immunologics, which is still private.  We track Quantum&#039;s value because of our buy.  Quantum does Dendritic Immunotherapy for breast cancer with the OFA protein found on 500 cancers.  This is just like Dendreon for Prostate cancer with the PAP protein, except 2 to 10 times as large an opportunity.  We invested because we feelo it is the next great breakthrough you were referring to.  Best in good health -- CB/MNTR</description>
		<content:encoded><![CDATA[<p>Mike  &#8212;  Love your reports.  Our firm, Mentor Capital (MNTR) has taken its first and a very large position in Quantum Immunologics, which is still private.  We track Quantum&#8217;s value because of our buy.  Quantum does Dendritic Immunotherapy for breast cancer with the OFA protein found on 500 cancers.  This is just like Dendreon for Prostate cancer with the PAP protein, except 2 to 10 times as large an opportunity.  We invested because we feelo it is the next great breakthrough you were referring to.  Best in good health &#8212; CB/MNTR</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Investment U</title>
		<link>http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html#comment-29321</link>
		<dc:creator>Investment U</dc:creator>
		<pubDate>Thu, 12 Nov 2009 15:48:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/investing-in-the-biotech-sector.html#comment-29321</guid>
		<description>Obi, 

Here is the info on &lt;a href=&quot;http://finance.yahoo.com/news/Poniard-Pharmaceuticals-to-prnews-4213669010.html?x=0&amp;.v=1&quot; rel=&quot;nofollow&quot;&gt;Poniard presenting on the 17th of November&lt;/a&gt;.  

Thank you, 

Investment U</description>
		<content:encoded><![CDATA[<p>Obi, </p>
<p>Here is the info on <a href="http://finance.yahoo.com/news/Poniard-Pharmaceuticals-to-prnews-4213669010.html?x=0&amp;.v=1" rel="nofollow">Poniard presenting on the 17th of November</a>.  </p>
<p>Thank you, </p>
<p>Investment U</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: obi</title>
		<link>http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html#comment-29266</link>
		<dc:creator>obi</dc:creator>
		<pubDate>Wed, 11 Nov 2009 21:55:30 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/investing-in-the-biotech-sector.html#comment-29266</guid>
		<description>where did you get the info on poniard presenting on the 17th of nov? its not on their website</description>
		<content:encoded><![CDATA[<p>where did you get the info on poniard presenting on the 17th of nov? its not on their website</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Investment U</title>
		<link>http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html#comment-29259</link>
		<dc:creator>Investment U</dc:creator>
		<pubDate>Wed, 11 Nov 2009 18:48:14 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/investing-in-the-biotech-sector.html#comment-29259</guid>
		<description>RP, 

As of June this year, there were 6 Biotech ETFs, each with their own strengths and weaknesses. They are:

iShares Nasdaq Biotechnology Trust (Nasdaq: &lt;a href=&quot;http://www.google.com/finance?q=NASDAQ%3AIBB&quot; rel=&quot;nofollow&quot;&gt;IBB&lt;/a&gt;)
HOLDRS Biotech ETF (NYSE: &lt;a href=&quot;http://www.google.com/finance?q=NYSE%3ABBH&quot; rel=&quot;nofollow&quot;&gt;BBH&lt;/a&gt;)
SPDR S&amp;P Biotech (NYSE: &lt;a href=&quot;http://www.google.com/finance?q=NYSE%3AXBI&quot; rel=&quot;nofollow&quot;&gt;XBI&lt;/a&gt;)
First Trust Amex Biotechnology Trust (NYSE: &lt;a href=&quot;http://www.google.com/finance?q=NYSE%3AFBT&quot; rel=&quot;nofollow&quot;&gt;FBT&lt;/a&gt;)
PowerShares Dynamic Biotech &amp; Genome Portfolio (NYSE: &lt;a href=&quot;http://www.google.com/finance?q=NYSE%3APBE&quot; rel=&quot;nofollow&quot;&gt;PBE&lt;/a&gt;)
PowerShares Global Biotech Portfolio (Nasdaq: &lt;a href=&quot;http://www.google.com/finance?q=NASDAQ%3APBTQ&quot; rel=&quot;nofollow&quot;&gt;PBTQ&lt;/a&gt;)

Thank you, 

Investment U</description>
		<content:encoded><![CDATA[<p>RP, </p>
<p>As of June this year, there were 6 Biotech ETFs, each with their own strengths and weaknesses. They are:</p>
<p>iShares Nasdaq Biotechnology Trust (Nasdaq: <a href="http://www.google.com/finance?q=NASDAQ%3AIBB" rel="nofollow">IBB</a>)<br />
HOLDRS Biotech ETF (NYSE: <a href="http://www.google.com/finance?q=NYSE%3ABBH" rel="nofollow">BBH</a>)<br />
SPDR S&amp;P Biotech (NYSE: <a href="http://www.google.com/finance?q=NYSE%3AXBI" rel="nofollow">XBI</a>)<br />
First Trust Amex Biotechnology Trust (NYSE: <a href="http://www.google.com/finance?q=NYSE%3AFBT" rel="nofollow">FBT</a>)<br />
PowerShares Dynamic Biotech &amp; Genome Portfolio (NYSE: <a href="http://www.google.com/finance?q=NYSE%3APBE" rel="nofollow">PBE</a>)<br />
PowerShares Global Biotech Portfolio (Nasdaq: <a href="http://www.google.com/finance?q=NASDAQ%3APBTQ" rel="nofollow">PBTQ</a>)</p>
<p>Thank you, </p>
<p>Investment U</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: RP O'Reilly</title>
		<link>http://www.investmentu.com/2009/November/investing-in-the-biotech-sector.html#comment-29251</link>
		<dc:creator>RP O'Reilly</dc:creator>
		<pubDate>Wed, 11 Nov 2009 16:49:00 +0000</pubDate>
		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/investing-in-the-biotech-sector.html#comment-29251</guid>
		<description>Can you name or sre their any Biotech ETFs? 

Thank you.</description>
		<content:encoded><![CDATA[<p>Can you name or sre their any Biotech ETFs? </p>
<p>Thank you.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

